Howe & Rusling’s Zymeworks ZYME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-25
Closed -$1K 896
2019
Q4
$1K Sell
25
-25
-50% -$908 ﹤0.01% 801
2019
Q3
$1K Hold
50
﹤0.01% 809
2019
Q2
$1K Hold
50
﹤0.01% 785
2019
Q1
$1K Hold
50
﹤0.01% 784
2018
Q4
$1K Hold
50
﹤0.01% 787
2018
Q3
$1K Hold
50
﹤0.01% 826
2018
Q2
$1K Buy
+50
New +$775 ﹤0.01% 788

Other funds holding ZYME

Howe & Rusling's ZYME Position: Q1 2020 in Review

Howe & Rusling sold out of Zymeworks (ZYME) in Q1 2020, closing a stake of 25 shares — an estimated $1K sold.

Howe & Rusling first reported a position in ZYME in Q2 2018 and held it in 7 quarters. The position peaked at $1K in Q4 2019. 116 funds tracked by Wall St. Rank hold ZYME as of Q1 2020.

  • Howe & Rusling reported no remaining Zymeworks position as of Q1 2020 after selling out during the quarter.
  • Howe & Rusling sold 25 Zymeworks shares in Q1 2020, an estimated $1K.
  • Howe & Rusling first reported a position in Zymeworks in Q2 2018 and held it in 7 quarters.
  • Howe & Rusling's Zymeworks position peaked at $1K in Q4 2019.
  • 116 funds tracked by Wall St. Rank held Zymeworks as of Q1 2020.

Based on Howe & Rusling's 13F filing for Q1 2020, filed 14 May 2020.